Skip to main content
Have a personal or library account? Click to login
Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients Cover

Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients

Radiology and Oncology
Volume 45 (2011): Issue 2 (June 2011)
By: ,  ,  ,  ,  ,   and    
Open Access
|Mar 2011
References

References

  1. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC. Early breast cancer.2009;: 1463-79.
    Open DOISearch in Google Scholar
  2. Plesnicar A, Golicnik M, Fazarinc IK, Kralj B, Kovac V, Plesnicar BK. Attitudes of midwifery students towards teaching breast-self examination.2010;: 52-6.
    Open DOISearch in Google Scholar
  3. Ovcaricek T. Frkovic SG, Matos E, Mozina B, Borstnar S. Triple negative breast cancer - prognostic factors and survival.2011;: 46-52.
    Open DOISearch in Google Scholar
  4. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008;: 69-81.
    Open DOISearch in Google Scholar
  5. Hickman JA, Beere HM, Wood AC, Waters CM, Parmar R. Mechanisms of cytotoxicity caused by antitumour drugs.1992;: 553-61.
    Open DOISearch in Google Scholar
  6. Ohmori T, Podack ER, Nishio K, Takahashi M, Miyahara Y, Takeda Y, et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2.1993;: 30-6.
    Open DOISearch in Google Scholar
  7. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ, Kohn KW. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.1993;: 1853-61.
    Search in Google Scholar
  8. Hagg M, Bivén K, Ueno T, Rydlander L, Björklund P, Wiman KG, et al. A novel high-through-put assay for screening of pro-apoptotic drugs.2002;: 253-9.
    Open DOISearch in Google Scholar
  9. Linder S. Cytokeratin markers come of age.2007;: 189-95.
    Open DOISearch in Google Scholar
  10. Ueno T, Toi M, Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement.2005;(Suppl): S359-62.
    Open DOISearch in Google Scholar
  11. Leers MP, Kölgen W, Björklund V, Bergman T, Tribbick G, Persson B, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neoepitope exposed during early apoptosis.1999;: 567-72.
    Open DOISearch in Google Scholar
  12. Zhang L, Kavanagh BD, Thorburn AM, Camidge DR. Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuli.2010;: 4478-89.
    Open DOISearch in Google Scholar
  13. Linder S, Olofsson MH, Herrmann R, Ulukaya E. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.2010;: 353-9.
    Open DOISearch in Google Scholar
  14. Holdenrieder S, Stieber P. Circulating apoptotic markers in the management of non-small cell lung cancer.2010;: 197-210.
    Open DOISearch in Google Scholar
  15. Brandt D, Volkmann X, Anstätt M, Länger F, Manns MP, Schulze-Osthoff K, et al. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas.2010;: 1464-73.
    Open DOISearch in Google Scholar
  16. de Haas EC, di Pietro A, Simpson KL, Meijer C, Suurmeijer AJ, Lancashire LJ, et al. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.2008;: 1041-8.
    Open DOISearch in Google Scholar
  17. Wu YX, Wang JH, Wang H, Yang XY. Study on expression of Ki-67, early apoptotic protein M30 in endometrial carcinoma and their correlation with prognosis.2003;: 314-8.
    Search in Google Scholar
  18. Yaman E, Coskun U, Sancak B, Buyukberber S, Ozturk B, Benekli M. Serum M30 levels are associated with survival in advanced gastric carcinoma patients.2010;: 719-22.
    Open DOISearch in Google Scholar
  19. Beachy SH, Repasky EA. Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update.2008;: 759-75.
    Open DOISearch in Google Scholar
  20. Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, Steiner G, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.2004;: 1751-6.
    Open DOISearch in Google Scholar
  21. Demiray M, Ulukaya EE, Arslan M, Gokgoz S, Saraydaroglu O, Ercan I, et al. Response to neoadjuvant chemotherapy in breast cancer could be predictable by measuring a novel serum apoptosis product, caspase-cleaved cytokeratin 18: a prospective pilot study.2006;: 669-76.
    Open DOISearch in Google Scholar
  22. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.1998;: 2672-85.
    Open DOISearch in Google Scholar
  23. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.1998;: 93-100.
    Open DOISearch in Google Scholar
  24. Scholl SM, Beuzeboc P, Harris AL, Pierga JY, Asselain B, Palangié T, et al. Is primary chemotherapy useful for all patients with primary invasive breast cancer? Recent results.1998;: 217-26.
    Search in Google Scholar
  25. Holdenrieder S, Stieber P. Apoptotic markers in cancer.2004;: 605-617.
    Open DOISearch in Google Scholar
  26. Degterev A, Yuan J. Expansion and evolution of cell death programmes.2008;: 378-90.
    Open DOISearch in Google Scholar
  27. Ozturk B, Coskun U, Sancak B, Yaman E, Buyukberber S, Benekli M. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.2009;: 645-8.
    Open DOISearch in Google Scholar
  28. Ueno T, Toi M, Bivén K, Bando H, Ogawa T, Linder S. Measurement of an apoptotic product in the sera of breast cancer patients.2003;: 769-74.
    Open DOISearch in Google Scholar
  29. Olofsson MH, Ueno T, Pan Y, Xu R, Cai F, van der Kuip H, et al. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.2007;: 3198-206.
    Open DOISearch in Google Scholar
  30. Ulukaya E, Yilmaztepe A, Akgoz S, Linder S, Karadag M. The levels of caspase cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.2007;: 399-404.
    Open DOISearch in Google Scholar
  31. Meyn RE, Stephens LC, Hunter NR, Milas L. Apoptosis in murine tumors treated with chemotherapy agents.1995;: 443-50.
    Open DOISearch in Google Scholar
  32. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer.1997;: 849.
    Open DOISearch in Google Scholar
  33. Green AM, Steinmetz ND. Monitoring apoptosis in real time.2002;: 82-92.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-011-0006-7 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 116 - 122
Published on: Mar 15, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
apoptosis,
chemotherapy,
M30,
response to chemotherapy,
breast cancer
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2011 Engin Ulukaya, Esra Karaagac, Ferda Ari, Arzu Oral, Saduman Adim, Asuman Tokullugil, Türkkan Evrensel, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 45 (2011): Issue 2 (June 2011)
Previous article
Next article